Tag: myelomonocytic leukemia

Biomarker, Innovation

Bone marrow cancer: Potential drug targets

March 17, 2022

Via: ScienceDaily

New research from Mayo Clinic’s Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia — an uncommon type of cancer of the bone marrow — have distinctive epigenetic changes that can activate harmful genes and cause the […]